Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Génétique des Maladies du Développement, |
RCV001004669 | SCV001164120 | uncertain significance | Developmental and epileptic encephalopathy, 43 | 2016-09-19 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001260774 | SCV001437866 | uncertain significance | Intellectual disability | 2020-09-10 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV002249619 | SCV002516429 | pathogenic | Epilepsy, childhood absence, susceptibility to, 5 | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003769407 | SCV004573335 | pathogenic | Epilepsy, childhood absence, susceptibility to, 1; Epilepsy, childhood absence, susceptibility to, 5 | 2023-11-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg232*) in the GABRB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GABRB3 are known to be pathogenic (PMID: 26950270, 28053010). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with GABRB3-related conditions (PMID: 28053010). ClinVar contains an entry for this variant (Variation ID: 813738). For these reasons, this variant has been classified as Pathogenic. |